World's Best Scientists 2026 revealed!
Journal of Cancer Research and Clinical Oncology
H-index 31

Journal of Cancer Research and Clinical Oncology

0171-5216

Published by: Springer

https://www.springer.com/journal/432

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 803 330 384 26

Additional Metrics

Number of Best Scientists*: 612
Documents by Best Scientists*: 636
Top 100 Ranked Scientists*: 6
SCIMAGO H-index: 114
SCIMAGO SJR: 0.91
Impact Factor: 2.8

Overview

Top Research Topics at Journal of Cancer Research and Clinical Oncology?

The journal primarily tackles Internal medicine, Hematology, Oncology, Cancer research and Pathology. Topics in Internal medicine were tackled in line with various other fields like Gastroenterology and Endocrinology. Hematology research featured in it incorporates concerns from various other topics such as Lung cancer, Surgery and Colorectal cancer.

The studies in Oncology featured incorporate elements of Survival rate, Retrospective cohort study, Proportional hazards model, Stage (cooking) and Survival analysis. The journal focuses on Cancer research but the discussions also offer insight into other areas such as Cell culture, Cell growth, Carcinogenesis, Apoptosis and Cancer cell. Research on Cell culture addressed in it frequently intersections with the field of Molecular biology.

Topics in Pathology explored in it were investigated in conjunction with research in Metastasis and Adenocarcinoma.

  • Internal medicine (59.85%)
  • Hematology (41.64%)
  • Oncology (23.45%)

What are the most cited papers published in the journal?

  • Randomized controlled trial of screening for hepatocellular carcinoma. (1007 citations)
  • Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR. (717 citations)
  • Inhibition of protein phosphatases by microcystins and nodularin associated with hepatotoxicity. (526 citations)

Research areas of the most cited articles at Journal of Cancer Research and Clinical Oncology:

The published articles mostly deal with topics like Internal medicine, Cancer research, Pathology, Cancer and Hematology. Issues in Internal medicine were discussed in the journal articles, taking into consideration concepts from other disciplines like Gastroenterology, Endocrinology, Surgery and Oncology. The Cancer research research tackled in the most cited articles is interrelated with Cell culture which concerns subjects like Molecular biology.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Gene

The previous edition focused in particular on these issues:

Journal of Cancer Research and Clinical Oncology mainly deals with areas of study such as Internal medicine, Hematology, Oncology, Cancer research and Cancer. Journal of Cancer Research and Clinical Oncology explores research in Internal medicine and the adjacent study of Gastroenterology. The studies on Hematology discussed can also contribute to research in the domains of Immunohistochemistry, Hepatocellular carcinoma, Proportional hazards model, Radiation therapy and Adenocarcinoma.

The Radiation therapy study featured falls within the larger field of Radiology. Oncology research presented in the journal encompasses a variety of subjects, including Adverse effect, Randomized controlled trial, Hazard ratio, Breast cancer and Cohort. The work on Cancer research tackled in the journal brings together disciplines like Cell growth, Cancer cell, Apoptosis, Downregulation and upregulation and Metastasis.

The most cited articles from the last journal are:

  • Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning (11 citations)
  • Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells (8 citations)
  • Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma (8 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal of Cancer Research and Clinical Oncology (based on the number of publications) are:

  • Maurie Markman (68 papers) absent at the last edition,
  • Andreas Hochhaus (46 papers) published 8 papers at the last edition, 6 more than at the previous edition,
  • Martin R. Berger (45 papers) published 2 papers at the last edition,
  • Zhao-You Tang (43 papers) absent at the last edition,
  • Dietrich Schmähl (36 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Cancer Research and Clinical Oncology (based on the number of publications) are:

  • German Cancer Research Center (212 papers) published 5 papers at the last edition, 1 less than at the previous edition,
  • Fudan University (187 papers) published 13 papers at the last edition, 5 more than at the previous edition,
  • Ludwig Maximilian University of Munich (185 papers) published 10 papers at the last edition, 8 less than at the previous edition,
  • Heidelberg University (136 papers) published 7 papers at the last edition, 2 more than at the previous edition,
  • University of Münster (109 papers) published 2 papers at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.40% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 14.43% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.85% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.75% of all publications and 57.97% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Oncology Research

The Journal of Cancer Research and Clinical Oncology, besides being a primer for groundbreaking cell culture research and radiology therapies, also serves as a beacon to those professionals who are thinking about pursuing a career in the field of Oncology. Given the wide range of topics that the journal deals with, there are several areas where professionals could potentially provide their expertise and make notable contributions.

For instance, specialists in West Virginia nursing license education requirements could apply the knowledge gained from the journal in regions that lack skilled personnel to address Oncology related issues, particularly ones that are specific to their area. A career in Oncology Research not only offers the opportunity to work in a rich and exciting field but also the ability to genuinely make a difference in people's lives.

From Internal Medicine to Molecular Biology, professionals equipped with a variety of specializations could find a place in Oncology Research, given its interdisciplinary nature. Often, collaborations across fields could lead to interesting insights and push the boundaries of current knowledge. As such, the field provides ample opportunities for continuous learning and professional growth.

Regardless of the specific area within Oncology that professionals choose to specialize in or the nature of their contributions – be it conducting research, publishing papers or treating patients, there is always the potential for remarkable impact. With the right focus and commitment, professionals could leave their mark in Oncology and spearhead advancements that pacify the distress caused by cancer.

Top Publications

  • Estimating the global burden of Epstein-Barr virus-related cancers.

    Yide Wong;Yide Wong;Michael T. Meehan;Scott R. Burrows;Scott R. Burrows;Denise L. Doolan;Denise L. Doolan

    (2021)
    278 Citations
  • Predictive biomarkers in gastric cancer

    (2022)
    107 Citations
  • Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry

    Sebastian Birndt;Thomas Schenk;Babett Heinevetter;Frank M. Brunkhorst

    (2020)
    103 Citations
  • Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters.

    Danjun Song;Yueyue Wang;Wentao Wang;Yining Wang

    (2021)
    65 Citations
  • Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board

    (2022)
    63 Citations
  • Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expression.

    Ken Masuda;Hidehito Horinouchi;Midori Tanaka;Ryoko Higashiyama

    (2021)
    57 Citations
  • Exercise medicine for cancer cachexia: targeted exercise to counteract mechanisms and treatment side effects

    (2022)
    46 Citations
  • Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors

    Kazuki Takada;Yasuto Yoneshima;Kentaro Tanaka;Isamu Okamoto

    (2020)
    43 Citations
  • Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas

    Ying Tian;Eri Arai;Satomi Makiuchi;Noboru Tsuda

    (2020)
    42 Citations
  • DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics.

    Felix K.F. Kommoss;Damian Stichel;Damian Stichel;Daniel Schrimpf;Daniel Schrimpf;Mark Kriegsmann

    (2020)
    37 Citations

Related Online Degrees & Career Pathways

For those interested in studying Medicine in the USA, exploring related online degrees can expand career opportunities and enhance your qualifications. Many Nursing professionals, for example, take advantage of flexible options like the bsn to msn online pathway, which provides an affordable and convenient bridge to advanced nursing roles.

Additionally, registered nurses seeking to advance their education without clinical hours can consider the rn to bsn no clinicals programs. These allow working professionals to earn their Bachelor of Science in Nursing online, balancing education with busy schedules.

For those aiming to pursue the highest nursing degrees quickly, accelerated dnp programs offer a streamlined route to a Doctor of Nursing Practice, enabling leadership and specialized clinical roles in a shorter timeframe.

Alternatively, if you're seeking a faster entry into the healthcare workforce, an accelerated medical assistant program can prepare you for a vital supportive role in medical settings in as little as six weeks.

These diverse online pathways highlight the flexibility and variety of options available for aspiring healthcare professionals, complementing a traditional medical education with practical and advanced qualifications.

Best Scientists Contributing to This Journal